Gayatri Gowrishankar1, Jonathan Hardy2, Mirwais Wardak1, Mohammad Namavari1, Robert E Reeves3, Evgenios Neofytou4, Ananth Srinivasan1, Joseph C Wu1,4, Christopher H Contag2, Sanjiv Sam Gambhir5,6. 1. Department of Radiology, Stanford University School of Medicine, Stanford, California. 2. Department of Pediatrics, Stanford University School of Medicine, Stanford, California. 3. Thermo Fisher Scientific, Hanover Park, Illinois. 4. Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California; and. 5. Department of Radiology, Stanford University School of Medicine, Stanford, California sgambhir@stanford.edu. 6. Department of Bioengineering, Stanford University School of Medicine, Stanford, California.
Abstract
6″-18F-fluoromaltotriose is a PET tracer that can potentially be used to image and localize most bacterial infections, much like 18F-FDG has been used to image and localize most cancers. However, unlike 18F-FDG, 6″-18F-fluoromaltotriose is not taken up by inflammatory lesions and appears to be specific to bacterial infections by targeting the maltodextrin transporter that is expressed in gram-positive and gram-negative strains of bacteria. Methods: 6″-18F-fluoromaltotriose was synthesized with high radiochemical purity and evaluated in several clinically relevant bacterial strains in cultures and in living mice. Results: 6″-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains. 6″-18F-fluoromaltotriose was also able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection. The utility of 6″-18F-fluoromaltotriose to help monitor antibiotic therapies was also evaluated in rats. Conclusion: 6″-18F-fluoromaltotriose is a promising new tracer that has significant diagnostic utility, with the potential to change the clinical management of patients with infectious diseases of bacterial origin.
6″-18F-fluoromaltotriose is a PET tracer that can potentially be used to image and localize most bacterial infections, much like 18F-FDG has been used to image and localize most cancers. However, unlike 18F-FDG, 6″-18F-fluoromaltotriose is not taken up by inflammatory lesions and appears to be specific to bacterial infections by targeting the maltodextrin transporter that is expressed in gram-positive and gram-negative strains of bacteria. Methods: 6″-18F-fluoromaltotriose was synthesized with high radiochemical purity and evaluated in several clinically relevant bacterial strains in cultures and in living mice. Results: 6″-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains. 6″-18F-fluoromaltotriose was also able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection. The utility of 6″-18F-fluoromaltotriose to help monitor antibiotic therapies was also evaluated in rats. Conclusion: 6″-18F-fluoromaltotriose is a promising new tracer that has significant diagnostic utility, with the potential to change the clinical management of patients with infectious diseases of bacterial origin.
Authors: Hannah Trøstrup; Kim Thomsen; Lars J Christophersen; Hans P Hougen; Thomas Bjarnsholt; Peter Ø Jensen; Nikolai Kirkby; Henrik Calum; Niels Høiby; Claus Moser Journal: Wound Repair Regen Date: 2013-02-25 Impact factor: 3.617
Authors: Kristin L Peterson; William C Reid; Alexandra F Freeman; Steven M Holland; Roderic I Pettigrew; Ahmed M Gharib; Dima A Hammoud Journal: Nucl Med Biol Date: 2013-03-27 Impact factor: 2.408
Authors: Edward A Weinstein; Alvaro A Ordonez; Vincent P DeMarco; Allison M Murawski; Supriya Pokkali; Elizabeth M MacDonald; Mariah Klunk; Ronnie C Mease; Martin G Pomper; Sanjay K Jain Journal: Sci Transl Med Date: 2014-10-22 Impact factor: 17.956
Authors: Luis A Diaz; Catherine A Foss; Katherine Thornton; Sridhar Nimmagadda; Christopher J Endres; Ovsev Uzuner; Thorsten M Seyler; Slif D Ulrich; Janet Conway; Chetan Bettegowda; Nishant Agrawal; Ian Cheong; Xiaosong Zhang; Paul W Ladenson; Barry N Vogelstein; Michael A Mont; Shibin Zhou; Kenneth W Kinzler; Bert Vogelstein; Martin G Pomper Journal: PLoS One Date: 2007-10-10 Impact factor: 3.240
Authors: Matthew F L Parker; Robert R Flavell; Justin M Luu; Oren S Rosenberg; Michael A Ohliger; David M Wilson Journal: ACS Infect Dis Date: 2020-06-09 Impact factor: 5.084
Authors: Filipa Mota; Alvaro A Ordonez; George Firth; Camilo A Ruiz-Bedoya; Michelle T Ma; Sanjay K Jain Journal: J Med Chem Date: 2020-02-21 Impact factor: 7.446
Authors: Christopher A Mutch; Alvaro A Ordonez; Hecong Qin; Matthew Parker; Lauren E Bambarger; Javier E Villanueva-Meyer; Joseph Blecha; Valerie Carroll; Celine Taglang; Robert Flavell; Renuka Sriram; Henry VanBrocklin; Oren Rosenberg; Michael A Ohliger; Sanjay K Jain; Kiel D Neumann; David M Wilson Journal: ACS Infect Dis Date: 2018-05-08 Impact factor: 5.084
Authors: Kiyoko Takemiya; Xinghai Ning; Wonewoo Seo; Xiaojian Wang; Rafi Mohammad; Giji Joseph; Jane S Titterington; Colleen S Kraft; Jonathan A Nye; Niren Murthy; Mark M Goodman; W Robert Taylor Journal: JACC Cardiovasc Imaging Date: 2018-04-18
Authors: Kiyoko Takemiya; Joachim J Røise; Maomao He; Chung Taing; Alexander G Rodriguez; Niren Murthy; Mark M Goodman; W Robert Taylor Journal: PLoS One Date: 2021-03-01 Impact factor: 3.240
Authors: Madeline G Sell; David A Alcorta; Andrew E Padilla; Dakota W Nollner; Nicole R Hasenkampf; Havard S Lambert; Monica E Embers; Neil L Spector Journal: J Clin Microbiol Date: 2021-06-18 Impact factor: 5.948